CVS Health — May 6, 2026 release

We will continue to build momentum through delivering on our strategy and a steadfast focus on our purpose - to simplify health care one person, one family and one community at a time.”                                                                                                            - David Joyner, CVS Health Chairman and CEO Three Months Ended March 31, Year Ending December 31, In billions, except per share amounts 2026 2025 2026 Projected Total revenues $ 100.4  $ 94.6  At least $405.0 Diluted earnings per share $ 2.30  $ 1.41  $6.24-$6.44 Adjusted EPS (2) $ 2.57  $ 2.25  $7.30-$7.50 Cash flow from operations $ 4.2  $ 4.6  At least $9.5 First quarter GAAP diluted EPS of $2.30 increased from $1.41 in the prior year. Adjusted EPS of $2.57 increased from $2.25 in the prior year, primarily due to improved adjusted operating income in the Health Care Benefits segment, reflecting continued execution on the Health Care Benefits segment margin recovery plan. The Company is increasing its full-year 2026 GAAP diluted EPS, Adjusted EPS and cash flow from operations guidance to reflect increases in the Health Care Benefits and Pharmacy & Consumer Wellness segments, while maintaining a cautious view for the remainder of the year in light of continued elevated cost trends and the potential for macro headwinds. 1 Consolidated first quarter results Three Months Ended March 31, In millions, except per share amounts 2026 2025 Change Total revenues $ 100,426  $ 94,588  $ 5,838  Operating income 4,680  3,374  1,306  Adjusted operating income (1) 5,150  4,579  571  Net income 2,957  1,782  1,175  Diluted earnings per share $ 2.30  $ 1.41  $ 0.89  Adjusted EPS (2) $ 2.57  $ 2.25  $ 0